Navigation Links
Blood Pressure Drugs May Help Heart Patients Without Hypertension
Date:3/1/2011

By Serena Gordon
HealthDay Reporter

TUESDAY, March 1 (HealthDay News) -- In people with heart disease, the use of blood pressure-lowering medications can be beneficial, even in those who don't have high blood pressure, new research suggests.

The study found that when people without high blood pressure were given blood pressure drugs, their risk of congestive heart failure, stroke, all-cause mortality and a combination of cardiovascular disease outcomes were reduced.

"If someone has had a previous heart attack or other cardiovascular event, and their blood pressure is in the normal range, they're still at risk of future cardiovascular events. There may be an additional benefit to giving an anti-hypertensive medication to these folks," said study author Angela M. Thompson, a doctoral research fellow in the department of epidemiology at Tulane University School of Public Health and Tropical Medicine in New Orleans.

"Current treatment recommendations advise treatment when the blood pressure is over 140/90 mm/Hg, but our study shows that you can obtain benefits even when the blood pressure is below that," Thompson explained.

In fact, the risk for cardiovascular disease begins at 115 mm/Hg of systolic pressure (the top number on a blood pressure reading), according to background information in the study.

In addition, in adults 55 years and older, the lifetime risk of developing hypertension is more than 90 percent, the study noted.

The study, which was funded by Tulane University and the National Institutes of Health, was published in the March 2 issue of the Journal of the American Medical Association.

Cardiovascular disease is the leading cause of death in the United States, according to background information in the study. About 54 percent of strokes and 46 percent of heart disease cases occur in people who have blood pressure levels in the normal range, the study reported.

The current study is a meta-analysis of 25 reports that were selected from a pool of 874 studies. The selected studies included almost 65,000 people without high blood pressure, and three-quarters of the study participants were men. All had a history of heart attack or other cardiovascular disease.

Most of the study volunteers were taking blood pressure medications known as beta blockers or angiotensin-converting enzyme (ACE) inhibitors, two commonly used classes of drugs for lowering blood pressure.

The researchers found that people taking blood pressure medications had a 23 percent reduced risk of stroke, a 29 percent reduced risk of congestive heart failure and a 15 percent reduction in the risk of a combination of cardiovascular events. In addition, the risk of cardiovascular mortality was reduced by 17 percent, and the risk of all-cause mortality dropped by 13 percent in those taking these medications compared to those who weren't on the drugs.

Thompson said the researchers don't know exactly how blood pressure medications lowered the risk of cardiovascular events, because this wasn't a study designed to look at the mechanism behind the effect.

He and the other researchers reported no conflicts of interest.

Dr. Mario Garcia, chief of cardiology at Montefiore Medical Center in New York City, said the findings were "not surprising or unexpected. These drugs all have beneficial effects beyond lowering blood pressure. These drugs have already been shown to prevent events in patients with heart attacks or heart failure."

Dr. Hector Ventura, director of cardiomyopathy and heart transplantation at the Ochsner Health System in New Orleans, said, "This study is kind of novel because they looked at people treated with blood pressure medications without hypertension. And, even in people without so-called hypertension, there might be a benefit from these medications," he said.

But, he said, there are still a lot of unanswered questions. In some cases, these medications could make blood pressure too low. And, people would likely need to be on these medications indefinitely, possibly for years. So, costs and potential side effects have to be considered, said Ventura, who wrote an accompanying editorial in the same issue of the journal.

In the editorial, Ventura concluded that the meta-analysis "demonstrates that treatment of blood pressures lower than 140/90 mm/Hg is associated with benefits for patients with [cardiovascular disease], but more clinical trial data are needed for those without CVD."

More information

Learn more about blood pressure medications from the American Heart Association.

SOURCES: Angela M. Thompson, M.S.P.H., doctoral research fellow, department of epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans; Hector Ventura, M.D., director, section of cardiomyopathy and heart transplantation, Ochsner Health System, New Orleans; Mario Garcia, M.D., chief, division of cardiology, Montefiore Medical Center and Albert Einstein College of Medicine, New York City; March 2, 2011, Journal of the American Medical Association


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Dramatic Drop in Blood Infections Among ICU Patients: CDC
2. A small subset of normal white blood cells gives rise to a rare leukemia, study shows
3. Simple blood test at discharge could help reduce hospital readmissions for heart failure patients
4. Neighborhood barbers can influence black men to seek blood-pressure treatment
5. Study finds close linkage between a rare, deadly lung condition and blood cell abnormalities
6. Blood pressure management: Sleep on it
7. Advanced degrees add up to lower blood pressure
8. Whole fresh blood for transfusions may have a longer shelf life than now assumed
9. Convenient blood test not as effective for diagnosing diabetes in children
10. Nanoparticles increase survival after blood loss
11. People With Bowel Disease at Higher Risk of Blood Clot in Lungs, Legs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blood Pressure Drugs May Help Heart Patients Without Hypertension
(Date:1/21/2017)... (PRWEB) , ... January 21, 2017 , ... ... of Alumni Relations, Dianne Travis-Teague, the electrifying line-up of events for its annual ... alumni, family, friends, and community. “Coming Home 2017” will be held on ...
(Date:1/20/2017)... ... January 20, 2017 , ... Spectrum Aquatics Launches New ADA Portable Motion Trek BP ... Since the lift is mounted on wheels, it can be wheeled out of the way ... to fasten to the deck. "We have transformed the feedback from customers into specific enhancements ...
(Date:1/20/2017)... ... January 20, 2017 , ... Bionic Sports Nutrition LLC, an American ... announced it had a successful January ECRM Trade Show in Hilton Head, SC. ... which allows it to provide its products to all clients at reasonable prices. At ...
(Date:1/20/2017)... ... ... "TransFlare 4K Mystique comes with 44 colorful mysterious transitions that are fully ... - CEO of Pixel Film Studios. , TransFlare 4K Mystique contains 44 lens ... and light leak transitions have a very high-dynamic range for super smooth falloff. Simply ...
(Date:1/20/2017)... ... 2017 , ... “I Forgive You”: a fine examination of how God handles sin, including ... of published author, Stephen Miller, who, for over ten long years has been waiting to ... in Trinidad and Tobago, he has been serving the Lord for over twenty years, and ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... 20, 2017  Today, during a plenary ... Pathways in Immunology, Growth Disorders and Cancer," ... INFI ) presented preclinical data for ... selectively inhibits phosphoinositide-3-kinase-gamma (PI3K-gamma). Preclinical data showed ... resistance to checkpoint inhibition by remodeling the ...
(Date:1/20/2017)... Research and Markets has announced the addition of the ... Electrolyte Testing, HbA1c Testing, Comprehensive Metabolic Panel, Liver Panel, Renal Panel, ... report to their offering. ... The global clinical laboratory testing market is expected to ... solutions on the grounds of maximum efficiency and minimum error is ...
(Date:1/20/2017)... 2017 Stock-Callers.com today evaluates the following ... ), Novo Nordisk A/S (NYSE: NVO ), Sucampo ... Holdings Inc. (NASDAQ: PTX ). These stocks belong ... th , 2017, finishing near its session lows. As per ... 0.7%, while shares of health care companies in the S&P ...
Breaking Medicine Technology: